Turnstone Biologics Corp. Undistributed Earnings (Loss) Allocated to Participating Securities, Basic
Turnstone Biologics Corp. reported Undistributed Earnings (Loss) Allocated to Participating Securities, Basic of $10.36 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2023-09-01.
Discontinued › Expense Statement
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic · last filed 2023-09-01
- Turnstone Biologics Corp. undistributed earnings (loss) allocated to participating securities, basic for the quarter ending 2022-06-30 was $10.36M.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic 3 month |
|---|---|
| 2022-06-30 | $10.36M 10-Q · filed 2023-09-01 |